nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—Methaemoglobinaemia—Riluzole—amyotrophic lateral sclerosis	0.0811	0.087	CcSEcCtD
Trimethoprim—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0479	0.0514	CcSEcCtD
Trimethoprim—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0319	0.0343	CcSEcCtD
Trimethoprim—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0259	0.0278	CcSEcCtD
Trimethoprim—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0224	0.024	CcSEcCtD
Trimethoprim—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0197	0.0211	CcSEcCtD
Trimethoprim—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0208	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0183	0.0197	CcSEcCtD
Trimethoprim—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0179	0.0193	CcSEcCtD
Trimethoprim—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0186	CcSEcCtD
Trimethoprim—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0175	CcSEcCtD
Trimethoprim—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0157	CcSEcCtD
Trimethoprim—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0152	CcSEcCtD
Trimethoprim—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.014	0.015	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0146	CcSEcCtD
Trimethoprim—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0144	CcSEcCtD
Trimethoprim—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0143	CcSEcCtD
Trimethoprim—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0143	CcSEcCtD
Trimethoprim—Depression—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0143	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0131	0.014	CcSEcCtD
Trimethoprim—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.013	0.0139	CcSEcCtD
Trimethoprim—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0136	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0135	CcSEcCtD
Trimethoprim—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0135	CcSEcCtD
Trimethoprim—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0134	CcSEcCtD
Trimethoprim—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0128	CcSEcCtD
Trimethoprim—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0127	CcSEcCtD
Trimethoprim—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0126	CcSEcCtD
Trimethoprim—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0126	CcSEcCtD
Trimethoprim—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0121	CcSEcCtD
Trimethoprim—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0112	0.012	CcSEcCtD
Trimethoprim—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0116	CcSEcCtD
Trimethoprim—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0116	CcSEcCtD
Trimethoprim—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0113	CcSEcCtD
Trimethoprim—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0112	CcSEcCtD
Trimethoprim—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00976	0.0105	CcSEcCtD
Trimethoprim—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00957	0.0103	CcSEcCtD
Trimethoprim—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0102	CcSEcCtD
Trimethoprim—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00936	0.01	CcSEcCtD
Trimethoprim—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00934	0.01	CcSEcCtD
Trimethoprim—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00932	0.01	CcSEcCtD
Trimethoprim—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00915	0.00983	CcSEcCtD
Trimethoprim—Cough—Riluzole—amyotrophic lateral sclerosis	0.00909	0.00976	CcSEcCtD
Trimethoprim—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00902	0.00969	CcSEcCtD
Trimethoprim—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00887	0.00952	CcSEcCtD
Trimethoprim—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00887	0.00952	CcSEcCtD
Trimethoprim—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00884	0.00949	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00881	0.00945	CcSEcCtD
Trimethoprim—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00857	0.0092	CcSEcCtD
Trimethoprim—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0085	0.00913	CcSEcCtD
Trimethoprim—Shock—Riluzole—amyotrophic lateral sclerosis	0.00836	0.00898	CcSEcCtD
Trimethoprim—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00834	0.00895	CcSEcCtD
Trimethoprim—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00832	0.00894	CcSEcCtD
Trimethoprim—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00826	0.00886	CcSEcCtD
Trimethoprim—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0081	0.0087	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00774	0.00831	CcSEcCtD
Trimethoprim—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00769	0.00825	CcSEcCtD
Trimethoprim—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00758	0.00814	CcSEcCtD
Trimethoprim—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00748	0.00803	CcSEcCtD
Trimethoprim—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00739	0.00793	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00734	0.00788	CcSEcCtD
Trimethoprim—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0078	CcSEcCtD
Trimethoprim—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00752	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00695	0.00746	CcSEcCtD
Trimethoprim—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00675	0.00725	CcSEcCtD
Trimethoprim—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00721	CcSEcCtD
Trimethoprim—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00721	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00669	0.0976	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00626	0.00672	CcSEcCtD
Trimethoprim—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00601	0.00646	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00584	0.0852	CbGpPWpGaD
Trimethoprim—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00624	CcSEcCtD
Trimethoprim—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00603	CcSEcCtD
Trimethoprim—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0054	0.0058	CcSEcCtD
Trimethoprim—Rash—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00575	CcSEcCtD
Trimethoprim—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00535	0.00575	CcSEcCtD
Trimethoprim—Headache—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00572	CcSEcCtD
Trimethoprim—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00505	0.00542	CcSEcCtD
Trimethoprim—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00441	0.0643	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0026	0.0379	CbGpPWpGaD
Trimethoprim—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00228	0.0333	CbGpPWpGaD
Trimethoprim—TYMS—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00212	0.031	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00186	0.0271	CbGpPWpGaD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00132	0.0193	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00132	0.0193	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00126	0.0183	CbGpPWpGaD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00123	0.018	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00108	0.0157	CbGpPWpGaD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000814	0.0119	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00074	0.0108	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000718	0.0105	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000689	0.0101	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000676	0.00987	CbGpPWpGaD
Trimethoprim—DHFR—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000658	0.00961	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000597	0.00872	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000597	0.00872	CbGpPWpGaD
Trimethoprim—TYMS—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000574	0.00838	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000534	0.00779	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000534	0.00779	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000522	0.00762	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TPK1—amyotrophic lateral sclerosis	0.000521	0.00761	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000521	0.00761	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000521	0.00761	CbGpPWpGaD
Trimethoprim—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.000509	0.00743	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000508	0.00741	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000466	0.0068	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000466	0.0068	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000454	0.00663	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000443	0.00647	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00044	0.00642	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000437	0.00637	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000437	0.00637	CbGpPWpGaD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000435	0.00635	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00042	0.00613	CbGpPWpGaD
Trimethoprim—DHFR—Disease—VTA1—amyotrophic lateral sclerosis	0.000417	0.00608	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000407	0.00595	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000399	0.00583	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000396	0.00578	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000394	0.00574	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000381	0.00556	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000381	0.00556	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000378	0.00552	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000371	0.00542	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000354	0.00517	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000349	0.0051	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000349	0.00509	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000332	0.00485	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000327	0.00477	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000324	0.00473	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00032	0.00468	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000316	0.00461	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—DAO—amyotrophic lateral sclerosis	0.000316	0.00461	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000305	0.00445	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000303	0.00442	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000303	0.00442	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PLB1—amyotrophic lateral sclerosis	0.000286	0.00417	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000286	0.00417	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000277	0.00405	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—DAO—amyotrophic lateral sclerosis	0.000276	0.00402	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000265	0.00386	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000263	0.00384	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000258	0.00376	CbGpPWpGaD
Trimethoprim—DHFR—Disease—VCP—amyotrophic lateral sclerosis	0.000255	0.00372	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000247	0.0036	CbGpPWpGaD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000245	0.00358	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000242	0.00354	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000239	0.00349	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000237	0.00346	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000232	0.00339	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000228	0.00333	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000226	0.00329	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000222	0.00323	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSR—amyotrophic lateral sclerosis	0.000221	0.00322	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00022	0.00321	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000211	0.00308	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00021	0.00306	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000209	0.00305	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000209	0.00304	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.0002	0.00291	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000197	0.00288	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSR—amyotrophic lateral sclerosis	0.000193	0.00281	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00019	0.00278	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000187	0.00272	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CST3—amyotrophic lateral sclerosis	0.000183	0.00267	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000181	0.00265	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000176	0.00257	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000174	0.00254	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000166	0.00242	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000161	0.00235	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000158	0.00231	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000143	0.00209	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000141	0.00206	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000141	0.00206	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000138	0.00201	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000136	0.00198	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000135	0.00198	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000135	0.00197	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000135	0.00197	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000135	0.00197	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000135	0.00197	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CASP9—amyotrophic lateral sclerosis	0.000133	0.00194	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00013	0.00189	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000126	0.00184	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000123	0.0018	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000123	0.00179	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000118	0.00172	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000118	0.00172	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000117	0.0017	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000115	0.00167	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB4—amyotrophic lateral sclerosis	0.000114	0.00166	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00011	0.0016	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00011	0.0016	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000108	0.00157	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000108	0.00157	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000104	0.00152	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000104	0.00152	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000102	0.00149	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0001	0.00147	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0001	0.00146	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	9.76e-05	0.00142	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.75e-05	0.00142	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.45e-05	0.00138	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.4e-05	0.00137	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.34e-05	0.00136	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.32e-05	0.00136	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.29e-05	0.00136	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.96e-05	0.00131	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	8.82e-05	0.00129	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APOE—amyotrophic lateral sclerosis	8.8e-05	0.00128	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.78e-05	0.00128	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.5e-05	0.00124	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	8.5e-05	0.00124	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.94e-05	0.00116	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.82e-05	0.00114	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	7.39e-05	0.00108	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—APOE—amyotrophic lateral sclerosis	7.37e-05	0.00108	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.31e-05	0.00107	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.24e-05	0.00106	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.24e-05	0.00106	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—amyotrophic lateral sclerosis	7e-05	0.00102	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	6.82e-05	0.000996	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.79e-05	0.00099	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.63e-05	0.000967	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.44e-05	0.00094	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOE—amyotrophic lateral sclerosis	6.43e-05	0.000938	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.22e-05	0.000907	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.16e-05	0.000899	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—amyotrophic lateral sclerosis	6.1e-05	0.000891	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—amyotrophic lateral sclerosis	6.03e-05	0.00088	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	6.02e-05	0.000878	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	5.95e-05	0.000868	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.79e-05	0.000845	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.76e-05	0.00084	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	5.6e-05	0.000818	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.55e-05	0.000811	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.24e-05	0.000764	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.11e-05	0.000746	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.06e-05	0.000738	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.05e-05	0.000737	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.88e-05	0.000713	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.56e-05	0.000666	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.41e-05	0.000643	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.35e-05	0.000635	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.16e-05	0.000607	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.97e-05	0.000579	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.66e-05	0.000535	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.5e-05	0.000511	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.01e-05	0.00044	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.01e-05	0.000439	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.85e-05	0.000416	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.77e-05	0.000404	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.62e-05	0.000383	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.45e-05	0.000358	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.41e-05	0.000352	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.28e-05	0.000332	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.25e-05	0.000329	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.98e-05	0.00029	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.85e-05	0.000271	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.62e-05	0.000236	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.56e-05	0.000228	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	0.000217	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.36e-05	0.000198	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.27e-05	0.000185	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000178	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.38e-06	0.000122	CbGpPWpGaD
